A seasoned business strategist with over a decade of experience in digital transformation and startup scaling.
A recent study reveals that people who come off new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass far faster than those who stop traditional lifestyle plans.
Findings released in a leading medical journal demonstrates that while obese people can lose substantial amounts of their total mass while on the medication, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"People buying these medications should be aware of the danger of fast rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to starting weight in about 18 months.
The study, which looked at dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.
The team point out that individuals who lose weight through dieting typically experience a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
Nutrition scientists propose the mode of action of the injections accounts for the amplified regain.
GLP-1 drugs copy a body's own chemical called GLP-1, which moderates appetite.
"Sustained high doses of the hormone levels far above than normal might result in the body to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement leads to appetite is uncontrolled, making excessive eating a significant risk."
The NHS advise the jabs for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.
Many experts say that, considering the significant potential of relapse, the treatment is often ongoing.
This perspective is echoed by pharmaceutical companies, who note that the results "emphasize the persistent character of excess weight," comparing it to managing conditions like diabetes.
Users who have discontinued the jabs describe a powerful return of cravings.
"It was like a switch activating and you're instantly starving," described an individual.
This difficulty is exacerbated if patients have not adopted lasting dietary or behavioural modifications during treatment.
Figures show that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
In conclusion, researchers stress that while the jabs are powerful agents for shedding pounds, they are not a magic fix and lasting health benefits likely depends on integrated behavioural support.
A seasoned business strategist with over a decade of experience in digital transformation and startup scaling.